Recro Pharma Inc (REPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | REPH | RCEL | NRXP | ||
| Company | Recro Pharma Inc | Avita Medical Inc | Nrx Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.07 | 4.66 | 3.25 | ||
| High | 2.14 | 5.59 | 3.50 | ||
| Low | 2.00 | 4.51 | 3.23 | ||
| Latest | 2.09 | 4.56 | 3.28 | ||
| Change | -0.01 | +0.20 | +0.07 | ||
| % Change | -0.48% | +4.59% | +2.18% | ||
| Volume | 141,800 | 1,218,300 | 2,251,900 | ||
| 20-Day Average Volume | 122,300 | 251,675 | 1,282,190 | ||
| Previous Close | 2.10 | 4.36 | 3.21 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.84 | 4.41 | 3.01 | ||
| 20-Day Raw Stochastic | 85.07% | 34.81% | 76.84% | ||
| 20-Day Relative Strength | 65.13 | 52.54 | 65.26 | ||
| Weighted Alpha | -25.90 | -34.94 | +45.36 | ||
| Today's Opinion | 40% Buy | 80% Buy | 72% Buy | ||
| Previous Opinion | 40% Buy | 40% Buy | 72% Buy | ||
| Last Month's Opinion | 56% Sell | 40% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.18% since 03/14/22 | +10.95% since 05/08/26 | +6.49% since 05/08/26 | ||
| Low | 1.94 on 03/15/22 | 4.11 on 05/11/26 | 2.74 on 05/12/26 | ||
| High | 2.19 on 03/18/22 | 5.59 on 05/15/26 | 3.50 on 05/15/26 | ||
| 1-Month | |||||
| %Chg | +30.62% since 02/18/22 | -11.63% since 04/15/26 | +30.16% since 04/15/26 | ||
| Low | 1.52 on 02/24/22 | 4.01 on 05/08/26 | 2.43 on 04/16/26 | ||
| High | 2.19 on 03/18/22 | 5.59 on 05/15/26 | 3.50 on 05/15/26 | ||
| 3-Month | |||||
| %Chg | +35.71% since 12/21/21 | +9.62% since 02/13/26 | +82.22% since 02/13/26 | ||
| Low | 1.42 on 01/31/22 | 3.53 on 03/27/26 | 1.62 on 03/09/26 | ||
| High | 2.19 on 03/18/22 | 5.92 on 02/24/26 | 3.50 on 05/15/26 | ||
| 6-Month | |||||
| %Chg | +1.95% since 09/21/21 | +21.60% since 11/14/25 | +31.73% since 11/14/25 | ||
| Low | 1.38 on 12/06/21 | 3.22 on 01/07/26 | 1.62 on 03/09/26 | ||
| High | 2.20 on 09/23/21 | 5.92 on 02/24/26 | 3.50 on 05/15/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 117,926 | 140,343 | 108,463 | ||
| Shares Outstanding, K | 56,424 | 30,777 | 33,068 | ||
| Annual Sales | 75,360,000 | 71,610,000 | 1,230,000 | ||
| Annual Net Income | -11,370,000 | -48,590,000 | -28,620,000 | ||
| Last Quarter Sales | 22,300,000 | 17,620,000 | 980,000 | ||
| Last Quarter Net Income | -2,360,000 | -11,620,000 | 360,000 | ||
| 60-Month Beta | 1.08 | 1.90 | 2.02 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.38 on 02/12/26 | 0.19 on 03/23/26 | ||
| Earnings Date | 05/05/22 | 08/06/26 | 05/18/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||